These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7471128)

  • 1. Controlled-release diethylpropion hydrochloride used in a program for weight reduction.
    Parsons WB
    Clin Ther; 1981; 3(5):329-35. PubMed ID: 7471128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double blind evaluation of long acting diethylpropion hydrochloride in obese patients from a general practice.
    Carney DE; Tweddell ED
    Med J Aust; 1975 Jan; 1(1):13-5. PubMed ID: 1092973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind controlled study of the use of diethylpropion hydrochloride (Tenuate) in obese patients in a rural practice.
    Elliott BJ
    N Z Med J; 1978 Oct; 88(622):321-2. PubMed ID: 282482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized double-blind placebo-controlled study of the long-term efficacy and safety of diethylpropion in the treatment of obese subjects.
    Cercato C; Roizenblatt VA; Leança CC; Segal A; Lopes Filho AP; Mancini MC; Halpern A
    Int J Obes (Lond); 2009 Aug; 33(8):857-65. PubMed ID: 19564877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Weight reduction in obese diabetics: a double-blind study of diethylpropionate (author's transl)].
    Bratusch-Marrain P; Dudczak R; Waldhäusl W
    Wien Klin Wochenschr; 1979 Jun; 91(13):455-8. PubMed ID: 380178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of behavioral techniques reinforced with an anorectic drug in a double-blind weight loss study.
    Abramson R; Garg M; Cioffari A; Rotman PA
    J Clin Psychiatry; 1980 Jul; 41(7):234-7. PubMed ID: 6993445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bupropion SR enhances weight loss: a 48-week double-blind, placebo- controlled trial.
    Anderson JW; Greenway FL; Fujioka K; Gadde KM; McKenney J; O'Neil PM
    Obes Res; 2002 Jul; 10(7):633-41. PubMed ID: 12105285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical assessment of the use of an anorectic drug in a total weight reduction program.
    McQuarrie HG
    Curr Ther Res Clin Exp; 1975 May; 17(5):437-43. PubMed ID: 805027
    [No Abstract]   [Full Text] [Related]  

  • 10. Bupropion SR vs. placebo for weight loss in obese patients with depressive symptoms.
    Jain AK; Kaplan RA; Gadde KM; Wadden TA; Allison DB; Brewer ER; Leadbetter RA; Richard N; Haight B; Jamerson BD; Buaron KS; Metz A
    Obes Res; 2002 Oct; 10(10):1049-56. PubMed ID: 12376586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of an appetite suppressant (diethylpropion hydrochloride) during pregnancy.
    Silverman M; Okun R
    Curr Ther Res Clin Exp; 1971 Oct; 13(10):648-53. PubMed ID: 5004802
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
    J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diethylpropion hydrochloride: an effective appetite suppressant.
    Bolding OT
    Curr Ther Res Clin Exp; 1974 Jan; 16(1):40-8. PubMed ID: 4203847
    [No Abstract]   [Full Text] [Related]  

  • 14. Three controlled trials of weight loss with phenylpropanolamine.
    Altschuler S; Conte A; Sebok M; Marlin RL; Winick C
    Int J Obes; 1982; 6(6):549-56. PubMed ID: 6761288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of an anorexic drug in a total weight reduction program in private practice.
    Nolan GR
    Curr Ther Res Clin Exp; 1975 Aug; 18(2):332-7. PubMed ID: 809245
    [No Abstract]   [Full Text] [Related]  

  • 16. Intermittent treatment with anorectic drugs.
    Silverstone T
    Practitioner; 1974 Aug; 213(1274):245-52. PubMed ID: 4609035
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of Elsinore tablets in the treatment of obesity. A controlled clinical trial].
    Malchow-Møller A; Larsen S; Hey H; Stokholm KH; Juhl E; Quaade F
    Ugeskr Laeger; 1980 Jun; 142(23):1496-9. PubMed ID: 6996253
    [No Abstract]   [Full Text] [Related]  

  • 18. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.
    McMahon FG; Weinstein SP; Rowe E; Ernst KR; Johnson F; Fujioka K;
    J Hum Hypertens; 2002 Jan; 16(1):5-11. PubMed ID: 11840224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of the overweight patients with cardiovascular disease: double-blind evaluation of an anorectic drug, diethylpropion hydrochloride.
    Evanselista I
    Curr Ther Res Clin Exp; 1968 May; 10(5):217-22. PubMed ID: 4967733
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy of obesity. The initial and continued effectiveness of tenuate in intermittent therapy of moderately and severely obese patients. Double-blind study].
    Albach E; Gianoli AC
    Fortschr Med; 1977 Sep; 95(33):2040-4. PubMed ID: 334650
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.